Lisa Tan

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance”.

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Nature Genetics(2023)10.1038/s41588-023-01592-8

N/A

1.9DataRank · unranked

88 citations

Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey +80 more

Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

Journal of Clinical Oncology(2024)10.1200/jco.24.00071

N/A

1.4DataRank · unranked

60 citations

Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski +19 more

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.18.423280

N/A

0DataRank · unranked

19 citations

Deborah R. Caswell, Natalie I. Vokes, Emily K. Law, Wei Wu, William Hill +43 more

CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.12.584638

N/A

0DataRank · unranked

3 citations

Philippe Gui, Wei Wu, D. Lucas Kerr, Lisa Tan, Dora Barbosa +10 more